DTP Communications

  • Notice to Prescribers

Updated BC-CfE Reference Documents Available for Use

Click here to link to Therapeutic Guidelines for Antiretroviral (ARV) Treatment of Adult HIV Infection

Click here to link to Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia

  • Guidance document

BC-CfE Eligibility Criteria for emtricitabine/tenofovir alafenamide (FTC/TAF; Descovy®)

  • Formulary Addition

Bictegravir-emtricitabine-tenofovir alafenamide (Biktarvy®)

  • Notice to Prescribers

Nevirapine XR (ViramuneTM XR) tablet substitution with Nevirapine 200mg tablets

  • Notice to Prescribers

Dolutegravir-containing Products (Tivicay®, Triumeq®) in Pregnancy and Use in Women of Reproductive Age

For more information: click here to link to BC-CfE Drug Safety Alerts

  • Notice of Program Launch

HIV Pre-Exposure Prophylaxis (PrEP)

Click here to link to BC-CfE PrEP Program Information

  • Notice to Prescribers

Generic antiretroviral products on BC-CfE Formulary

  • Formulary Addition

Raltegravir 600mg HD tablet (Isentress™ HD)

  • Formulary Addition and Criteria

Elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide (Genvoya™)

  • Formulary Addition and Criteria

Emtricitabine-tenofovir alafenamide (Descovy™)

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

Start typing and press enter to search